CAMBRIDGE, Mass. - Immuneering Corporation (NASDAQ:IMRX), a clinical-stage oncology company with a market capitalization of $59.31 million, has entered into a clinical supply agreement with Regeneron ...

Here’s the latest traffic and travel news from around Northern Ireland. The Mandeville Road in Craigavon has been closed during Friday's evening rush hour after a crash. Diversions are in place ...

Cramer discussed how Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) keeps getting undermined despite the company’s rich pipeline and its strength in drug development. “How about Regeneron?

With a market cap of $77.3 billion, Regeneron Pharmaceuticals, Inc. (REGN) is a leading biotechnology company dedicated to discovering, developing, and commercializing innovative treatments for a ...

Regeneron Pharmaceuticals Inc.'s executives and board members ... a shareholder derivative lawsuit filed Thursday says. The company’s reimbursing of credit processing card fees for drug distributors ...

Part of the company’s interest in joining the Truveta ... senior vice president of Regeneron and head of its Genetics Center. “We don’t have tremendous data platforms in this country ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

While the patent cliff in EYLEA has challenged Regeneron's revenue growth, the company seems poised to overcome this obstacle in the coming quarters and years. The consensus EPS expectation of $44 ...

Ahead of the new League of Ireland season, Gavin Cummiskey updates us on the efforts of teams with title aspirations to recruit centre forwards capable of knocking in a heap of goals, while in ...

Ireland's native trees play crucial ecological ... that can set cookies on your device and collect data about your activity. Please review their details and accept them to load the content.Manage ...

Regeneron describes itself as a “biotechnology company that designs products for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, among others.” ...

[Image from Aerogen] Aerogen announced today that it plans to invest about $308.5 million (€300 million) to expand operations in Ireland. The company — headquartered in Dangan, Galway — expects its ...